The SIV fragments tested were selected because they are key immunogens examined as relevant gene products in other published research [14,15] Those studies had shown toxoids of Tat or Tat and Rev, or delivery of aggregated multiantigens, provided some disease attenuation [5,6] whereas use of Tat alone for example, provided only temporary infection containment. This evidence concerns the gene TAT and infection.